Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Calvez

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
HIV Medicine|May 26, 2010
Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patientsS Lambert-Niclot, N Machouf, G Peytavin, et al.
HIV Medicine|July 16, 2008
Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor-sparing therapy in patients with lipoatrophy: results from the 96-week randomized ANRS 108 NoNuke TrialM A Valantin, E Lanoy, M Bentata, et al.
The British Journal of Dermatology|June 3, 1999
The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcomaN Dupin, V Rubin De Cervens, I Gorin, et al.
HIV Medicine|January 22, 2003
P-glycoprotein in blood CD4 cells of HIV-1-infected patients treated with protease inhibitorsP Bossi, O Legrand, A-M Faussat, et al.
Antimicrobial Agents and Chemotherapy|December 5, 2012
HIV-1 dynamics and coreceptor usage in Maraviroc-treated patients with ongoing replicationP Recordon-Pinson, S Raymond, P Bellecave, et al.
Transplantation|June 1, 2000
Outcome of kidney transplant recipients with previous human herpesvirus-8 infectionC Francès, C Mouquet, A G Marcelin, et al.
The Journal of Antimicrobial Chemotherapy|February 29, 2012
Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimensA G Marcelin, C Charpentier, M Wirden, et al.
Lancet (London, England)|September 12, 2001
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot studyY Benhamou, M Bochet, V Thibault, et al.
Presse Medicale (Paris, France : 1983)|March 27, 1999
[Immunologic reconstruction after antiretroviral treatment]R Tubiana, G Carcelain, H A Mohand, et al.
European Journal of Neurology|October 26, 1999
Plasma and cerebrospinal fluid human immunodeficiency virus type-1 (HIV-1) RNA levels in HIV-related cognitive impairmentB Stankoff, V Calvez, S Suarez, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
HIV Medicine|May 26, 2010
Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100 mg in treatment-naïve HIV-infected patientsS Lambert-Niclot, N Machouf, G Peytavin, et al.
HIV Medicine|July 16, 2008
Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor-sparing therapy in patients with lipoatrophy: results from the 96-week randomized ANRS 108 NoNuke TrialM A Valantin, E Lanoy, M Bentata, et al.
The British Journal of Dermatology|June 3, 1999
The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcomaN Dupin, V Rubin De Cervens, I Gorin, et al.
HIV Medicine|January 22, 2003
P-glycoprotein in blood CD4 cells of HIV-1-infected patients treated with protease inhibitorsP Bossi, O Legrand, A-M Faussat, et al.
Antimicrobial Agents and Chemotherapy|December 5, 2012
HIV-1 dynamics and coreceptor usage in Maraviroc-treated patients with ongoing replicationP Recordon-Pinson, S Raymond, P Bellecave, et al.
Transplantation|June 1, 2000
Outcome of kidney transplant recipients with previous human herpesvirus-8 infectionC Francès, C Mouquet, A G Marcelin, et al.
The Journal of Antimicrobial Chemotherapy|February 29, 2012
Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimensA G Marcelin, C Charpentier, M Wirden, et al.
Lancet (London, England)|September 12, 2001
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot studyY Benhamou, M Bochet, V Thibault, et al.
Presse Medicale (Paris, France : 1983)|March 27, 1999
[Immunologic reconstruction after antiretroviral treatment]R Tubiana, G Carcelain, H A Mohand, et al.
European Journal of Neurology|October 26, 1999
Plasma and cerebrospinal fluid human immunodeficiency virus type-1 (HIV-1) RNA levels in HIV-related cognitive impairmentB Stankoff, V Calvez, S Suarez, et al.
Pageof 15